Global Generic Growth Stragen operates in over 60 markets with a focus on selected and advanced generics, presenting a scalable opportunity for sales teams to expand into diverse geographies through existing affiliates and partner networks.

Consumer Health Expansion In addition to generics, Stragen is diversifying into Consumer Health products, opening cross-selling opportunities with current partners and potential co-development or distribution arrangements for non-prescription healthcare solutions.

European Manufacturing All final products are 100% manufactured in Europe under Swiss quality standards, a strong selling point for customers seeking reliable supply chains and high-quality API and finished-dose products within regulated markets.

R&D Led Innovation The company emphasizes fundamental research and proof-of-concept for patented new drugs, offering potential collaboration on early-stage development programs, regulatory support, and strategic licensing opportunities.

Strategic Partnerships With a global partner network and dedicated affiliates, there is clear potential to structure co-marketing, exclusive distribution, or franchise-like arrangements for Stragen’s generics and consumer health lines in key regions.